Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage
In their recent publication, Song Li and Tatjana C. Jakobs, researchers at Harvard’s Schepens Eye Research Institute in Boston, Massachusetts, report an exciting discovery. They have identified Vitamin C as a potential neuroprotective substance that could be used clinically in patients suffering from glaucoma.
The neurodegenerative disease glaucoma is characterized by retinal degradation due to ganglion cell death as well as an increased number of reactive astrocytes in the optic nerve – cells that show abnormal functional and morphological patterns. Disease progression is associated with vision loss.
Lowering increased intraocular pressure (IOP) – the only current treatment option
There are several factors that increase the risk for getting glaucoma, including family history, age, and elevated intraocular pressure (IOP) due to aqueous fluid buildup in the eye. This can either be caused by increased fluid production or faulty drainage through the trabecular meshwork. Of these risk factors, IOP is the only one that is modifiable by treatment, either through medication or surgery. However, these treatments are not always successful. It is therefore highly desirable to identify supportive treatment options that protect the retina and slow down or even prevent ganglion cell death during glaucoma.
The scientific breakthrough of Li’s and Jakobs’ research consists of identifying substances that protect the retinal tissue from degradation and can therefore postpone or prevent vision loss significantly. The study focuses on a neuroprotective state of astrocytes. Astrocytes react to retinal ganglion cell (RGC) damage by adapting a short-term neuroprotective state that is characterized by a decreased expression of toxic mediators and an up-regulation of genes associated with neuroprotection, including increased phagocytosis, oxidative phosphorylation and the release of neurotropic factors that support overall RGC survival. A potential strategy for further drug development, besides the decrease of IOP, is therefore the identification of substances that regulate and upkeep this supportive astrocyte state.
Vitamin C enhances retinal ganglion cell (RGC) survival via SPP1 mediation
In a previous study, Li and Jakobs have demonstrated that the protein SPP1 (secreted phosphoprotein 1) has strong neuroprotective effects: it promotes RGC survival and thus helps to maintain visual function. However, using SPP1 as a direct treatment agent would be difficult. It would require intravitreal injection which can cause complications and retinal damage. Therefore, in this study, Li and Jakobs set out to identify small molecules that would enhance SPP1-expression, and they successfully identified both vitamin A and C. The toxicity of high vitamin A dosage limits its application possibilities, prompting Li and Jakobs to study the effects of Vitamin C more closely.
This research approach was successful: Treating astrocytes in in vitro culture with Vitamin C or its sodium salt (sodium ascorbate) showed an upregulation in SPP1. Additionally, the astrocytes assumed their neuroprotective state upon treatment. This happened in a SPP1-dependent manner since spp1-knock out (KO) astrocytes did not adopt a neuroprotective state. Similarly, applying Vitamin C to the retina increased SPP1 expression in retinal ganglion cells, and it had the same effect on astrocytes as in culture.
Results were confirmed when applied to glaucoma mouse models
To demonstrate the beneficial effect of inducing the neuroprotective astrocyte phenotype for glaucoma disease, Li and Jakobs worked with a mouse model of glaucoma disease. In these mice, IOP was increased by injecting microbeads into one eye, which interferes with aqueous humor drainage. The mice show reduced survival of retinal ganglion cells and reduced visual function in the modified eye, while the other eye serves as a control. When Vitamin C was administered to such mice through drinking water, visual function and RGC survival showed a significant increase in comparison to control groups that did not receive Vitamin C. Li and Jakobs used Striatech’s OptoDrum to determine the visual behavior of their mice. With the OptoDrum, they could demonstrate at the behavioral level that microbead injection worsened vision specifically in the injected eye, and that Vitamin C had positive effects, measuring the visual function for each eye independently.
Vitamin C was clearly beneficial in vivo, improved the functional readouts in the treated mice, and it also reduced the IOP. Interestingly, these benefits were also observed in spp1-KO animals, which somewhat contradicts the earlier findings that Vitamin C acts through an SPP1-dependent pathway in astrocytes. One possibility was that the reduction of IOP was sufficient to increase ganglion cell survival, and that Vitamin C activation of the SPP1 pathway is not required in this model. To test this, the researchers performed an additional set of experiments with an IOP-independent mouse model of ganglion cell death, the optic nerve crush model. In this model, RGC protection by Vitamin C was detected only in wild type mice, not in spp1-KO mice, suggesting that Vitamin C can indeed have a SPP1-mediated neuroprotective effect also in vivo. This SPP1-mediated action of Vitamin C has not been known before, and it adds to many known beneficial roles of Vitamin C in the body.
The clinical potential of Vitamin C administration in humans
How is this applicable to humans? Mice can synthesize their own Vitamin C via the GULO-gene, which is only a pseudogene in humans. This means that we rely on dietary supplementation of Vitamin C in our day-to-day life. Excessive intake of Vitamin C beyond the recommended daily dose of 75-90 mg is excreted through the urine and has not shown any beneficial effects. In fact, very high (>2 g per day) Vitamin C supply can even cause gastrointestinal disturbances. The authors suggest that patients that are already optimally supplied with Vitamin C through a healthy diet may not benefit from additional Vitamin C. However, a sizable number of patients may have suboptimal Vitamin C intake, and this can increase the rate of RGC loss and hasten disease progression. Indeed, a clear correlation has been observed in patients between lower Vitamin C concentration in the serum and increased IOP. This could suggest that increasing Vitamin C intake can be beneficial in such glaucoma patients. The additional administration of Vitamin C cannot replace other treatments in glaucoma patients, but the positive effects of sticking to dietary guidelines are very likely.
Blog author:
Emilia Kawecka, University of Tübingen, Student Assistant at Striatech
Original paper:
Li, S., Jakobs, T. C. Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage. Life Sci Alliance 6(8), (2023). doi:10.26508/lsa.202301976
Other sources:
Mohan N, Chakrabarti A, Nazm N, Mehta R, Edward DP. Newer advances in medical management of glaucoma. Indian J Ophthalmol. 2022 Jun;70(6):1920-1930. doi: 10.4103/ijo.IJO_2239_21.
Li S, Jakobs TC. Secreted phosphoprotein 1 slows neurodegeneration and rescues visual function in mouse models of aging and glaucoma. Cell Rep. 2022 Dec 27;41(13):111880. doi: 10.1016/j.celrep.2022.111880.
More OptoDrum Publications
The role of inflammation in hereditary spastic paraplegia type 11
- Related Products:
- OptoDrum/
Loss of Sarm1 reduces retinal ganglion cell loss in chronic glaucoma
Increasing the number and intensity of shock tube generated blast waves leads to earlier retinal ganglion cell dysfunction and regional cell death
- Related Products:
- OptoDrum/
Preservation of Intrinsically Photosensitive Retinal Ganglion Cells (ipRGCs) in Late Adult Mice: Implications as a Potential Biomarker for Early Onset Ocular Degenerative Diseases
- Related Products:
- OptoDrum/
Sustained Vision Recovery by OSK Gene Therapy in a Mouse Model of Glaucoma
Divergent phenotypes in constitutive versus conditional mutant mouse models of Sifrim-Hitz-Weiss syndrome
- Related Products:
- OptoDrum/
Selective deletion of zinc transporter 3 in amacrine cells promotes retinal ganglion cell survival and optic nerve regeneration after injury
- Related Products:
- OptoDrum/
Assessment of Visual Function and Retinal Histology in a Snf2h Knockout Mouse Model
- Related Products:
- OptoDrum/
- Applications:
- Chromatin Remodelling>
Microglia-mediated demyelination protects against CD8+ T cell-driven axon degeneration in mice carrying PLP defects
- Related Products:
- OptoDrum/
Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis
- Related Products:
- OptoDrum/
Microglia preserve visual function in the aging retina by supporting retinal pigment epithelial health
Modeling MOG Antibody-Associated Disorder and Neuromyelitis Optica Spectrum Disorder in Animal Models: Visual System Manifestations
- Related Products:
- OptoDrum/
Erythropoietin Protects against Retinal Damage in A Rat Model of Optic Neuropathy via Glial Suppression
- Related Products:
- OptoDrum/
The BET PROTAC inhibitor dBET6 protects against retinal degeneration and inhibits the cGAS-STING in response to light damage
- Related Products:
- OptoDrum/
Vitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage
- Related Products:
- OptoDrum/
Alleviating early demyelination in ischaemia/reperfusion by inhibiting sphingosine-1-phosphate receptor 2 could protect visual function from impairment
- Related Products:
- OptoDrum/
A visual opsin from jellyfish enables precise temporal control of G protein signalling
- Related Products:
- OptoDrum/
Cytotoxic CNS-associated T cells drive axon degeneration by targeting perturbed oligodendrocytes in PLP1 mutant mice
- Related Products:
- OptoDrum/
- Applications:
- Axon Degeneration>
Off Starburst Amacrine Cells in the Retina Trigger Looming-Evoked Fear Responses in Mice
- Related Products:
- OptoDrum/
- Applications:
- Looming-Evoked Fear Responses>
CRISPR-mediated optogene expression from a cell-specific endogenous promoter in retinal ON-bipolar cells to restore vision
- Related Products:
- OptoDrum/
Postsynaptic neuronal activity promotes regeneration of retinal axons
- Related Products:
- OptoDrum/
MCT1-dependent energetic failure and neuroinflammation underlie optic nerve degeneration in Wolfram syndrome mice
- Related Products:
- OptoDrum/
CyclinD2-mediated regulation of neurogenic output from the retinal ciliary margin is perturbed in albinism
- Related Products:
- OptoDrum/
- Applications:
- Albino Visual System>
Neurovascular injury associated non-apoptotic endothelial caspase-9 and astroglial caspase-9 mediate inflammation and contrast sensitivity decline
- Related Products:
- OptoDrum/
Bipolar cell targeted optogenetic gene therapy restores parallel retinal signaling and high-level vision in the degenerated retina
- Related Products:
- OptoDrum/
- Applications:
- Retinal Degeneration>
Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome
- Related Products:
- OptoDrum/
Targeting Cholesterol Homeostasis Improves Recovery in Experimental Optic Neuritis
- Related Products:
- OptoDrum/
Immune responses in mice after blast-mediated traumatic brain injury TBI autonomously contribute to retinal ganglion cell dysfunction and death
- Related Products:
- OptoDrum/
- Applications:
- Traumatic Brain Injury (TBI)>
Identification of Nitric Oxide-Donating Ripasudil Derivatives with Intraocular Pressure Lowering and Retinal Ganglion Cell Protection Activities
In situ-crosslinked hydrogel-induced experimental glaucoma model with persistent ocular hypertension and neurodegeneration
- Related Products:
- OptoDrum/
Noninvasive Ophthalmic Imaging Measures Retinal Degeneration and Vision Deficits in Ndufs4−/− Mouse Model of Mitochondrial Complex I Deficiency
- Related Products:
- OptoDrum/
Gain-of-function mutations in ALPK1 cause an NF-κB-mediated autoinflammatory disease: functional assessment, clinical phenotyping and disease course of patients with ROSAH syndrome
- Related Products:
- OptoDrum/
Stage-Dependent Changes of Visual Function and Electrical Response of the Retina in the rd10 Mouse Model
- Related Products:
- OptoDrum/
TNF-α stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3/miR-21a-5p axis
- Related Products:
- OptoDrum/
- Applications:
- Retinal Ischemia-Reperfusion Injury>
Chronic Proinflammatory Signaling Accelerates the Rate of Degeneration in a Spontaneous Polygenic Model of Inherited Retinal Dystrophy
- Related Products:
- OptoDrum/
- Applications:
- Retinal Degeneration>
B cell-dependent EAE induces visual deficits in the mouse with similarities to human autoimmune demyelinating diseases
- Related Products:
- OptoDrum/
- Applications:
- Autoimmune Demyelinating Diseases>
Systemic Treatment with Pioglitazone Reverses Vision Loss in Preclinical Glaucoma Models
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune En-cephalomyelitis
- Related Products:
- OptoDrum/
Accumulation of cytotoxic T cells in the aged CNS leads to axon degeneration and contributes to cognitive and motor decline
- Related Products:
- Applications:
Conditional Deletions of Hdc Confirm Roles of Histamine in Anaphylaxis and Circadian Activity but Not in Autoimmune Encephalomyelitis
- Related Products:
- OptoDrum/
- Applications:
- Multiple Sclerosis>
Immune modulation attenuates infantile neuronal ceroid lipofuscinosis in mice before and after disease onset
- Related Products:
- OptoDrum/
- Applications:
- Neuroinflammation>
Abundant Neural circRNA Cdr1as Is Not Indispensable for Retina Maintenance
- Related Products:
- OptoDrum/
- Applications:
Tau modulates visual plasticity in adult and old mice
- Related Products:
- OptoDrum/
- Applications:
Sex- and region-biased depletion of microglia/macrophages attenuates CLN1 disease in mice
- Related Products:
- OptoDrum/
Molecular basis of impaired extraocular muscle function in a mouse model of congenital myopathy due to compound heterozygous Ryr1 mutations
- Related Products:
- OptoDrum/
- Applications:
- Congenital Myopathy>
Empowering Retinal Gene Therapy with a Specific Promoter for Human Rod and Cone ON-Bipolar Cells
- Related Products:
- OptoDrum/
Nogo-A-targeting antibody promotes visual recovery and inhibits neuroinflammation after retinal injury
- Related Products:
- OptoDrum/
- Applications:
- Neuroinflammation>
Rod nuclear architecture determines contrast transmission of the retina and behavioral sensitivity in mice
- Applications:
The contrast sensitivity function of a small cryptobenthic marine fish
- Related Products:
- OptoDrum/
- Applications:
Effects of the jimpy mutation on mouse retinal structure and function
- Related Products:
- OptoDrum/
Characterization of a mouse model with complete RPE loss and its use for RPE cell transplantation
- Related Products:
- OptoDrum/
Characterizing visual performance in mice: an objective and automated system based on the optokinetic reflex
- Related Products:
- OptoDrum/